Agent View

Machine representations

Inspect the same governed public record as Markdown, structured data, or a retrieval endpoint.

Canonical entity
alpha:company:ed5c886b-f007-4eec-951c-0141de4aae25
Schema
alpha.governance.entity.public.v1
Last reviewed
2026-09-05T21:30:34.215281+00:00
Verification
source_reported
Ownership
unclaimed

Markdown

https://registry.alpha.ac/companies/eli-lilly-co.md
Open Markdown

Lilly (Eli)

Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero.

Record

FieldValue
Representationalpha-profile-markdown-v3
ProtocolAlpha Governance Facts Protocol 0.1
Schemaalpha.governance.entity.public.v1
Record versionpublic-1
Canonical entityalpha:company:ed5c886b-f007-4eec-951c-0141de4aae25
Entity typeCompany
Canonical URLhttps://registry.alpha.ac/companies/eli-lilly-co
PublicationPUBLISHED
Verificationsource_reported
Verification schemaalpha-verification-states-v1
Ownershipunclaimed
Published claims36
Claims under review1
Evidence records8
Conflicts0
Conflicts in internal review0
Observed2026-09-05T21:30:34.215281+00:00
Last reviewed2026-09-05T21:30:34.215281+00:00

Identity

  • Legal name: ELI LILLY & Co
  • Display name: Lilly (Eli)

Leadership

  • David Ricks: Chair. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:ed5c886b-f007-4eec-951c-0141de4aae25:3.
  • Carolyn R. Bertozzi, Ph.D.: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:ed5c886b-f007-4eec-951c-0141de4aae25:4.
  • Gabrielle Sulzberger: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:ed5c886b-f007-4eec-951c-0141de4aae25:5.
  • J. Erik Fyrwald: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:ed5c886b-f007-4eec-951c-0141de4aae25:5.
  • Jamere Jackson: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:ed5c886b-f007-4eec-951c-0141de4aae25:5.
  • Jon Moeller: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:ed5c886b-f007-4eec-951c-0141de4aae25:4.
  • Juan R. Luciano: Lead Independent Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:ed5c886b-f007-4eec-951c-0141de4aae25:5.
  • Katherine Baicker, Ph.D.: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:ed5c886b-f007-4eec-951c-0141de4aae25:5.
  • Kimberly Johnson: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:ed5c886b-f007-4eec-951c-0141de4aae25:5.
  • Mary Lynne Hedley, Ph.D.: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:ed5c886b-f007-4eec-951c-0141de4aae25:5.
  • Ralph Alvarez: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:ed5c886b-f007-4eec-951c-0141de4aae25:5.
  • William G. Kaelin Jr., M.D.: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:ed5c886b-f007-4eec-951c-0141de4aae25:5.
  • William Kaelin, Jr.: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:ed5c886b-f007-4eec-951c-0141de4aae25:6.
  • Adrienne Brown: Executive Vice President and President, Lilly Immunology. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:ed5c886b-f007-4eec-951c-0141de4aae25:7.
  • Anat Hakim: Executive Vice President, General Counsel and Secretary. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:ed5c886b-f007-4eec-951c-0141de4aae25:7.
  • Carole Ho: Executive Vice President and President, Lilly Neuroscience. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:ed5c886b-f007-4eec-951c-0141de4aae25:7.
  • Daniel Skovronsky: Executive Vice President, Chief Scientific and Product Officer and President, Lilly Research Laboratories. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:ed5c886b-f007-4eec-951c-0141de4aae25:7.
  • David Ricks: Chair, President, and Chief Executive Officer (CEO). Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:ed5c886b-f007-4eec-951c-0141de4aae25:7.
  • Diogo Rau: Executive Vice President and Chief Information and Digital Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:ed5c886b-f007-4eec-951c-0141de4aae25:7.
  • Edgardo Hernandez: Executive Vice President and President, Manufacturing Operations. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:ed5c886b-f007-4eec-951c-0141de4aae25:7.
  • Eric Dozier: Executive Vice President, Chief People Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:ed5c886b-f007-4eec-951c-0141de4aae25:7.
  • Ilya Yuffa: Executive Vice President and President, Lilly USA and Global Customer Capabilities. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:ed5c886b-f007-4eec-951c-0141de4aae25:7.
  • Jacob Van Naarden: Executive Vice President, President, Lilly Oncology and Head of Corporate Business Development. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:ed5c886b-f007-4eec-951c-0141de4aae25:7.
  • Kenneth Custer: Executive Vice President and President, Lilly Cardiometabolic Health. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:ed5c886b-f007-4eec-951c-0141de4aae25:7.
  • Lucas Montarce: Executive Vice President and Chief Financial Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:ed5c886b-f007-4eec-951c-0141de4aae25:7.
  • Melissa Seymour: Executive Vice President, Global Quality. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:ed5c886b-f007-4eec-951c-0141de4aae25:7.
  • Patrik Jonsson: Executive Vice President and President, Lilly International. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:ed5c886b-f007-4eec-951c-0141de4aae25:7.

Roles

  • PUBLISHED

Governance

  • NOT_ASSERTED

Board committees

  • PUBLISHED

Financials

  • NOT_ASSERTED

Workforce

  • NOT_ASSERTED

Market and index context

  • S&P 500 (SPX). Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:ed5c886b-f007-4eec-951c-0141de4aae25:8.

Legal Name

  • ELI LILLY & Co. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:ed5c886b-f007-4eec-951c-0141de4aae25:1.

Headquarters

  • US. Publication: UNDER_REVIEW. Verification: source_reported. Assertion: source_reported. Evidence: unlinked, under review.

Entity Status

  • Public listing published. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:ed5c886b-f007-4eec-951c-0141de4aae25:1.

Official Website

  • https://www.lilly.com. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:ed5c886b-f007-4eec-951c-0141de4aae25:2.

Published Fact

  • US. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:ed5c886b-f007-4eec-951c-0141de4aae25:1.
  • IN. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:ed5c886b-f007-4eec-951c-0141de4aae25:1.
  • Healthcare. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:ed5c886b-f007-4eec-951c-0141de4aae25:1.
  • Drug Manufacturers. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:ed5c886b-f007-4eec-951c-0141de4aae25:1.
  • https://www.lilly.com. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:ed5c886b-f007-4eec-951c-0141de4aae25:2.

Coverage states

FieldValue
IdentityPUBLISHED
BusinessPUBLISHED
LeadershipPUBLISHED
Board and committeesPUBLISHED
GovernanceNOT_ASSERTED
FinancialsNOT_ASSERTED
WorkforceNOT_ASSERTED
OwnershipNOT_ASSERTED
RatingsNOT_PUBLISHED
Market and index contextPUBLISHED

Public sources

Rights

FieldValue
public_retrievalallowed
agent_retrievalallowed
redistributionnot_granted
model_trainingnot_granted
commercial_usenot_specified
relationship_pathfindingnot_granted
direct_contactnot_granted

Limitations

  • Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
  • Only explicitly published canonical company identity and current confirmed public roles are included.
  • Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
  • Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
  • This Company Profile is an identity and evidence record, not an Alpha rating.

Alternate representations